[Phenobarbital in the pharmacotherapy of neonatal jaundices (a review of the literature)].
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000818:Animals; D001663:Bilirubin / Q000378:metabolism; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004899:Erythroblastosis, Fetal / Q000517:prevention & control; D005260:Female; D005954:Glucosephosphate Dehydrogenase / Q000502:physiology; D014453:Glucuronosyltransferase / Q000502:physiology; D006801:Humans; D007231:Infant, Newborn; D007567:Jaundice, Neonatal / Q000188:drug therapy* / Q000201:enzymology / Q000378:metabolism; D010634:Phenobarbital / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D010653:Phenylbutazone / Q000627:therapeutic use; D011247:Pregnancy; D011295:Prenatal Care
D000305:Adrenal Cortex Hormones; D005954:Glucosephosphate Dehydrogenase; D014453:Glucuronosyltransferase; D010653:Phenylbutazone; D001663:Bilirubin; D010634:Phenobarbital
Fenobarbital v farmakoterapii zheltukh novorozhdennykh (obzor literatury.